Your browser doesn't support javascript.
loading
Effects of vedolizumab in Japanese patients with Crohn's disease: a prospective, multicenter, randomized, placebo-controlled Phase 3 trial with exploratory analyses.
Watanabe, Kenji; Motoya, Satoshi; Ogata, Haruhiko; Kanai, Takanori; Matsui, Toshiyuki; Suzuki, Yasuo; Shikamura, Mitsuhiro; Sugiura, Kenkichi; Oda, Kazunori; Hori, Tetsuharu; Araki, Takahiro; Watanabe, Mamoru; Hibi, Toshifumi.
Afiliação
  • Watanabe K; Department of Intestinal Inflammation Research, Hyogo College of Medicine, Hyogo, Japan.
  • Motoya S; IBD Center, Hokkaido Prefectural Welfare Federation of Agricultural Cooperative, Sapporo-Kosei General Hospital, Sapporo, Japan.
  • Ogata H; Endoscopic Center, Keio University School of Medicine, Tokyo, Japan.
  • Kanai T; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Matsui T; Department of Gastroenterology, Fukuoka University Chikushi Hospital, Fukuoka, Japan.
  • Suzuki Y; Department of Internal Medicine, Toho University Medical Center Sakura Hospital, Chiba, Japan.
  • Shikamura M; Takeda Development Center Japan, Takeda Pharmaceutical Company Limited, Osaka, Japan.
  • Sugiura K; Takeda Development Center Japan, Takeda Pharmaceutical Company Limited, Osaka, Japan.
  • Oda K; Regenerative Medicine Unit, Takeda Pharmaceutical Company Limited, Kanagawa, Japan.
  • Hori T; Takeda Development Center Japan, Takeda Pharmaceutical Company Limited, Osaka, Japan.
  • Araki T; Takeda Development Center Japan, Takeda Pharmaceutical Company Limited, Osaka, Japan.
  • Watanabe M; Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.
  • Hibi T; Center for Advanced Inflammatory Bowel Disease Research and Treatment, Kitasato University Kitasato Institute Hospital, 5-9-1 Shirokane, Minato-ku, Tokyo, 108-8462, Japan. thibi@insti.kitasato-u.ac.jp.
J Gastroenterol ; 55(3): 291-306, 2020 Mar.
Article em En | MEDLINE | ID: mdl-31836930
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fármacos Gastrointestinais / Doença de Crohn / Anticorpos Monoclonais Humanizados Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: J Gastroenterol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fármacos Gastrointestinais / Doença de Crohn / Anticorpos Monoclonais Humanizados Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: J Gastroenterol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão